Evaluation Of Patients With Myelodysplastic Syndrome (MDS) Up To Age Seventy-Five, Referred For Allogeneic Hematopoietic Cell Transplant (HCT) Including Donor Availability And HCT Outcomes

✍ Scribed by T.L. Field; J. Perkins; J. Kim; M.A. Kharfan-Dabaja; H.F. Fenandez; L. Perez; J. Lancet; R.S. Komrokji; L. Ochoa-Bayona; M. Alsina; A. List; C. Anasetti

• Book ID: 116281254
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 78 KB
• Volume: 16
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2009.12.023